N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy

Sponsor: Médipôle Lyon-Villeurbanne • ClinicalTrials.gov ID: NCT07041710

Registry updated: 2026-10-09
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Changes in taste and smell can occur during chemotherapy treatment. These chemotherapy-related side effects can negatively impact patients' quality of life and diet. The aim of this research is therefore to propose a solution to alleviate these taste and smell disorders. Based on the same principle as rehabilitation proposed for anosmia (loss of smell) related to COVID-19, we hypothesize that olfactory rehabilitation (using the sense of smell) through the odorous properties of essential oils could be effective for chemotherapy-related taste and smell alterations.

Interventions

  • experimental in day hospital (Other)
    multidisciplinary day hospital
  • taste and smell disorders questionnaire (Other)
    Answer to the home-made questionnaire at inclusion and at 6 months

Eligibility criteria

Inclusion Criteria: * cancer treated with chemotherapy * patient with taste and/or smell disorders Exclusion Criteria: * patient at the end of chemotherapy treatment

Conditions

Cancer

Locations

  • Médipôle Hôpital Mututaliste — Villeurbanne, France
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record